Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling studyZoster Published on 2024-05-282024-09-05 Journal: Human vaccines & immunotherapeutics [Category] update2024, [키워드] Aging population Asia-Pacific herpes zoster mass vaccination Older adults Post-herpetic neuralgia public health impact recombinant zoster vaccine Singapore vaccination [DOI] 10.1080/21645515.2024.2348839 PMC 바로가기 [Article Type] Zoster
Prevalence and factors associated with hepatitis b vaccination uptake and completion among communities targeted for mass vaccination in gulu: a cross-sectional studyResearch Published on 2024-03-202024-09-05 Journal: BMC Public Health [Category] update2024, [키워드] hepatitis B Hepatitis B vaccination mass vaccination [DOI] 10.1186/s12889-024-18330-2 PMC 바로가기 [Article Type] Research
Comparison of SARS-CoV-2 Vaccination Skepticism, Reasons, and Concerns Between Mass Vaccination Centers and General Practices in Germany 2021Original Research Published on 2023-11-072024-09-05 Journal: Molecular pharmacology [Category] update2024, [키워드] Attitude to Health COVID-19 immunization programs mass vaccination Vaccination hesitancy Vaccines [DOI] 10.2147/PPA.S433331 PMC 바로가기 [Article Type] Original Research
The role of the mass vaccination programme in combating the COVID-19 pandemic: An LSTM-based analysis of COVID-19 confirmed casesarticle Published on 2023-03-082024-09-05 Journal: Heliyon [Category] update2024, [키워드] confirmed cases COVID-19 deep learning LSTM mass vaccination [DOI] 10.1016/j.heliyon.2023.e14397 PMC 바로가기 [Article Type] article
[Cost-effectiveness of universal childhood vaccination against hepatitis A in Spain: a dynamic approach]Article Published on 2023-03-012023-05-31 Journal: Gaceta sanitaria [Category] A형 간염, [키워드] Análisis de coste-beneficio Child Cost-benefit analysis España Hepatitis A vaccines Infant Lactantes mass vaccination Preescolares Spain Vacunación masiva Vacunas frente a la hepatitis A. [DOI] 10.1016/j.gaceta.2023.102292
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine Vaccine breakthrough Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
COVID-19 mass vaccination – an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaignsArticle Published on 2022-12-012023-07-08 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), [키워드] COVID-19 mass vaccination medical device public health vaccination capacity. [DOI] 10.1080/22221751.2022.2048968 PMC 바로가기
Outcomes of hepatitis B immunoglobulin and hepatitis B vaccination in high-risk newborns born to HBeAg-positive mothersArticle Published on 2022-10-012023-06-12 Journal: Biomedical journal [Category] B형 간염, Fulltext, [키워드] Hepatitis B Antibodies Hepatitis B e antigens mass vaccination [DOI] 10.1016/j.bj.2021.11.007 PMC 바로가기
Comparative effectiveness and durability of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign진행중인 전국적인 대규모 예방접종 캠페인에서 COVID-19 사망 및 중증 질환에 대한 예방접종의 비교 효과 및 지속성Article Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] 95% confidence interval Active surveillance acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Ad26 Ad26.COV2.S adjusted age all age groups approved BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 Cohort Cohort studies Comparative coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccines death dose doses Effectiveness effort immunogenicity intubation mass vaccination morbidity Mortality mRNA mRNA-1273 National of BNT162b2 offer offered pandemic prevented reduce registry data remained SARS-CoV-2 severe disease study period vaccinate vaccination Vaccine vaccine effectiveness variant variants waned were used [DOI] 10.1002/jmv.27934 PMC 바로가기 [Article Type] Article
Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021Article Published on 2022-09-012022-11-16 Journal: Eurosurveillance [Category] SARS, 변종, [키워드] approaches Beta BNT162b2 mRNA Can children Cohort complementary COVID-19 COVID-19 vaccination Europe Evidence help indirect protective effect individual Infection infection rate mass vaccination offer offered outbreak population immunity PROTECT Protective provided reduction Region regions remained Spread the SARS-CoV-2 unique vaccinated individual vaccination Vaccine variant [DOI] 10.2807/1560-7917.ES.2022.27.39.2101027 PMC 바로가기